Founder's role line (READ): "ATP-dependent chromatin-remodeling complex that controls nucleosome positioning and transcriptional accessibility." Key components (READ): ARID1A/B, SMARCA4 (BRG1), SMARCB1 (SNF5), PBRM1
DRY status
DRY: none located. Queries run:
"dry fasting" DNA methylation epigenetic OR immune OR VEGF OR Myc OR EZH2 human study(English)сухое голодание метилирование ДНК иммунитет лимфоциты исследование Филонов(Russian)
MEASURED: neither opened human dry-fasting study reports ARID1A, ARID1B, SMARCA4, SMARCB1 or PBRM1. One opened dry-fasting study reports ACTR3B as upregulated; ACTR3B is an actin-related protein and is not a SWI/SNF subunit. Stated so it is not mistaken for one.
Disconfirming and null first
- The best fasting chromatin study in existence for this node names no SWI/SNF subunit. Korenfeld N, Charni-Natan M, Bruse J, et al. Nucleic Acids Research. 2025;53(1):gkae1161. doi:10.1093/nar/gkae1161. PMID 39673515. Mouse C57BL/6JOlaHsd, 30 days of alternate-day fasting (15 cycles of 24 h fast and 24 h refeed), liver, ATAC-seq plus ChIP. MEASURED: the ChIP antibodies were PPARalpha, H3K4me1, H3K27ac and H3K27me3. No remodeler antibody was used. No SWI/SNF component is named in the reported results. The Introduction refers generically to "chromatin-remodeling enzymes" without naming any. This is a null for subunit identification in the one study that had the readout.
- Specific motif nulls in that study: GR, CREB and C/EBPbeta motifs were not enriched in ADF-fasted-activated enhancers. PPARalpha protein levels were unchanged by ADF.
- Human: nothing located. No human fasting study measuring any SWI/SNF subunit or nucleosome positioning was located.
- Note on an internal inconsistency in the source, reported rather than smoothed: the Methods give mice as 6 weeks old at the start and the Results give 8 weeks. The page does not resolve it.
Graded rows
| # | Claim | Modality | Species / system | Tier | Grade | Source | Tag |
|---|---|---|---|---|---|---|---|
| 36.1 | Repeated fasting changed hepatic chromatin accessibility at 23,629 of 182,151 accessible sites (about 13 percent): 11,571 more accessible, 12,058 less accessible | IF-ADF | mouse liver, in vivo | A1 | C | Korenfeld 2025 | MEASURED |
| 36.2 | Only about 6 percent of the 182,151 accessible sites were promoter-proximal, so most are likely enhancers | IF-ADF | mouse liver | A1 | C | Korenfeld 2025 | MEASURED |
| 36.3 | Footprinting predicted higher post-ADF activity for PPARalpha, PAR bZIP, Fox and HNF4alpha, and lower for CREB, AP-1 and ETS | IF-ADF | mouse liver | A1 | C | Korenfeld 2025 | MEASURED |
| 36.4 | The node's function (nucleosome accessibility) demonstrably moves under fasting; the node's identity (which remodeler did it) is unmeasured. Hop: accessibility changed, SWI/SNF is an accessibility remodeler, therefore SWI/SNF changed. The second premise does not license the conclusion, because ISWI, CHD and INO80 families also remodel accessibility and none was measured either | IF-ADF | hops shown | M | C | Korenfeld 2025, hops stated | MEASURED premise, inference shown and NOT accepted |
Conflict left unresolved
None located. There is no competing study because there is no study that measured the subunits.
Open questions
- Any fasting modality, any species, with SMARCA4, ARID1A, ARID1B, SMARCB1 or PBRM1 measured: nothing located.
- Whether the Korenfeld accessibility changes are SWI/SNF-dependent is testable by a remodeler ChIP or a conditional knockout under ADF. No such experiment was located.
← 35. Polycomb / PRC2 (EZH2) All 41 nodes 37. DNA methylation machinery →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.